|By PR Newswire||
|March 6, 2014 06:01 PM EST||
LAS VEGAS, March 6, 2014 /PRNewswire/ -- After three and a half weeks of selecting a jury from a pool of 400 Clark County citizens, opening statements are set to begin this Monday morning, March 10, 2014, in the Actos trial, a landmark case in which the plaintiffs are seeking the largest jury award in Nevada history! Japanese pharmaceutical giant Takeda is accused of failing to inform consumers and medical professionals about the risk of bladder cancer associated with its drug Actos. Actos, released in 1999, was marketed as a drug to treat Type II diabetes by helping sensitize cells to insulin, thus assisting in blood sugar control.
The Law Offices of Eglet Wall Christiansen represent the plaintiffs who are now bladder cancer patients, and who are among the first in the country to have their case heard against Takeda Pharmaceuticals. Monday, lead trial counsel Robert Eglet will begin laying out the product liability case for jurors.
"The link to bladder cancer from Actos was well documented time and time again and yet medical professionals and consumers were never advised of these risks," stated Robert Eglet, lead trial counsel of Eglet Wall Christiansen. "These pharmaceutical companies have a responsibility to fully disclose to the consumer all of the facts so that they can make an informed decision weighing not only the benefits but the risks of the drugs. And unfortunately, due to Takeda Pharmaceutical's conscious decision to keep this information from consumers and their doctors, we now have patients who are left to bear the permanent injury caused by Actos. That's why we will be asking for a multi-billion dollar punitive damage verdict," continued Eglet.
A multi-billion dollar verdict would be the largest verdict in Nevada history. Mr. Eglet, current National Trial Lawyer of the Year, holds the three largest personal injury verdicts in Nevada history and more multi-million dollar verdicts than any trial attorney in Nevada history.
Eglet concluded, "This could have been avoided. This should have been avoided. And we are going to make sure Takeda is held responsible for their actions."
About Eglet Wall Christiansen
Eglet Wall Christiansen's primary focus has been representing victims of defective products or drugs, auto accidents, wrongful death, insurance bad faith and commercial trucking accidents. Earlier this week, the firm was named by the National Law Journal as one of the best 12 Plaintiffs' firms in the country. Eglet Wall Christiansen Trial Attorneys is located at 400 South Seventh Street, Las Vegas, NV 89101.
Contact: Tom Letizia 702-545-8777
SOURCE Law Offices of Eglet Wall Christiansen
Mar. 29, 2017 03:15 PM EDT Reads: 661
Technology innovation is the driving force behind modern business and enterprises must respond by increasing the speed and efficiency of software delivery. The challenge is that existing enterprise applications are expensive to develop and difficult to modernize. This often results in what Gartner calls "Bimodal IT," where business struggle to apply modern tools and practices to traditional monolithic applications. But these existing assets can be modernized and made more efficient without havin...
Mar. 29, 2017 03:15 PM EDT Reads: 2,630
Mar. 29, 2017 03:15 PM EDT Reads: 248
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Mar. 29, 2017 03:15 PM EDT Reads: 2,206
Mar. 29, 2017 02:30 PM EDT Reads: 661
Mar. 29, 2017 02:30 PM EDT Reads: 3,799
Mar. 29, 2017 02:30 PM EDT Reads: 2,269
Mar. 29, 2017 02:15 PM EDT Reads: 3,244
Mar. 29, 2017 01:30 PM EDT Reads: 537
Mar. 29, 2017 01:30 PM EDT Reads: 2,245
Mar. 29, 2017 01:30 PM EDT Reads: 1,737
Mar. 29, 2017 12:45 PM EDT Reads: 725
Mar. 29, 2017 12:15 PM EDT Reads: 7,898
Mar. 29, 2017 11:45 AM EDT Reads: 2,573
Mar. 29, 2017 11:00 AM EDT Reads: 3,435